ArticleAntimicrobial agents and chemotherapy2014

Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A.

Jill Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.